Association between the 21-gene recurrence score and isolated locoregional recurrence in stage I-II, hormone receptor-positive breast cancer by David D. Yang, Daniela L. Buscariollo, Angel M. Cronin, Shicheng Weng, Melissa E. Hughes, Richard J. Bleicher, Adam L. Cohen, Sara H. Javid, Stephen B. Edge, Beverly Moy, Joyce C. Niland, Antonio C. Wolff, Michael J. Hassett, Rinaa S. Punglia

Subjects: Get full text

Application of 21-Gene test in adjuvant radiotherapy for early breast cancer by TANG Xiaolu, HUA Xin, CAO Lu, CHEN Jiayi

Subjects: “…|breast cancer|radiotherapy|21-gene recurrence score…”
Get full text

Should women with early breast cancer under 40 years of age have a routine 21-gene recurrence score testing: A SEER database study by Kai-Hua Liu, Lei Zhang, Jian-Xian Chen, Chen-Lu Lian, Jun Wang, Zhen-Yu He, San-Gang Wu

Subjects: Get full text

Spotlight on the utility of the Oncotype DX® breast cancer assay by Siow ZR, De Boer RH, Lindeman GJ, Mann GB

Subjects: Get full text

A nomogram to predict the high-risk RS in HR+/HER2-breast cancer patients older than 50 years of age by Jing Yu, Jiayi Wu, Ou Huang, Jianrong He, Li Zhu, Weiguo Chen, Yafen Li, Xiaosong Chen, Kunwei Shen

Subjects: Get full text

Adjuvant chemotherapy and survival among patients 70 years of age and younger with node-negative breast cancer and the 21-gene recurrence score of 26–30 by Seho Park, Yunan Han, Ying Liu, Adetunji T. Toriola, Lindsay L. Peterson, Graham A. Colditz, Seung Il Kim, Young Up Cho, Byeong-Woo Park, Yikyung Park

Subjects: Get full text

Enhancing clinical decision support with genomic tools in breast cancer: A Scottish perspective by A.L. Peters, P.S. Hall, L.B. Jordan, F.Y. Soh, L. Hannington, S. Makaranka, G. Urquhart, M. Vallet, D. Cartwright, H. Marashi, B. Elsberger

Subjects: Get full text

Comparisons of tumor-infiltrating lymphocyte levels and the 21-gene recurrence score in ER-positive/HER2-negative breast cancer by Sung Gwe Ahn, Yoon Jin Cha, Soon June Bae, Chanik Yoon, Hak Woo Lee, Joon Jeong

Subjects: Get full text

Efficacy of adjuvant chemotherapy stratified by age and the 21-gene recurrence score in estrogen receptor-positive breast cancer by Jing Yu, Caijin Lin, Jiahui Huang, Jin Hong, Weiqi Gao, Siji Zhu, Lin Lin, Xiaosong Chen, Ou Huang, Jianrong He, Li Zhu, Weiguo Chen, Yafen Li, Jiayi Wu, Kunwei Shen

Subjects: Get full text

Application of a 21-Gene Recurrence Score in a Swiss Single-Center Breast Cancer Population: A Comparative Analysis of Treatment Administration before and after TAILORx by Elena Diana Chiru, Anton Oseledchyk, Andreas Schoetzau, Christian Kurzeder, Raphael Mosimann, Marcus Vetter, Cvetka Grašič Kuhar

Subjects: Get full text

Practice patterns and outcomes for patients with node-negative hormone receptor-positive breast cancer and intermediate 21-gene Recurrence Scores by Jonathan Chen, Xian Wu, Paul J. Christos, Silvia Formenti, Himanshu Nagar

Subjects: Get full text

The regrouping of Luminal B (HER2 negative), a better discriminator of outcome and recurrence score by Zheng‐Jun Yang, Yu‐Xiao Liu, Yue Huang, Zu‐Jin Chen, Hao‐Zhi Zhang, Yue Yu, Xin Wang, Xu‐Chen Cao

Subjects: Get full text

21-gene recurrence score in predicting the outcome of postoperative radiotherapy in T1-2N1 luminal breast cancer after breast-conserving surgery by Shang-Jin Xie, Run-Jie Wang, San-Gang Wu, Fu-Xing Zhang

Subjects: Get full text

Cost-effectiveness of a 21-gene recurrence score assay versus Canadian clinical practice in women with early-stage estrogen- or progesterone-receptor-positive, axillary lymph-node... by Hannouf Malek B, Xie Bin, Brackstone Muriel, Zaric Gregory S

Subjects: Get full text

21-Gene Recurrence Score Assay and Outcomes of Adjuvant Radiotherapy in Elderly Women With Early-Stage Breast Cancer After Breast-Conserving Surgery by San-Gang Wu, Wen-Wen Zhang, Jun Wang, Yong Dong, Jia-Yuan Sun, Yong-Xiong Chen, Zhen-Yu He

Subjects: Get full text

Clinicopathological characteristics and genomic profiling of pure mucinous breast cancer by Qianyi Lu, Hanxing Zhou, Jianwei Zhang, Kaping Lee, Limin Chen, Ruoxi Hong, Kuikui Jiang, Fei Xu, Wen Xia, Boyang Cao, Jingmin Zhang, Kang Shao, Peng Sun, Shusen Wang

Subjects: Get full text

Evaluating the Risk of Breast Cancer Recurrence and Metastasis After Adjuvant Tamoxifen Therapy by Integrating Polymorphisms in Cytochrome P450 Genes and Clinicopathological Charac... by Hui Pang, Guoqiang Zhang, Na Yan, Na Yan, Jidong Lang, Jidong Lang, Yuebin Liang, Yuebin Liang, Xinyuan Xu, Yaowen Cui, Xueya Wu, Xianjun Li, Ming Shan, Xiaoqin Wang, Xiangzhi Meng, Jiaxiang Liu, Geng Tian, Geng Tian, Li Cai, Dawei Yuan, Xin Wang

Subjects: Get full text

Assessment High-Risk Breast Cancer in Older Patients: A Comparative Analysis of PREDICT Scores and TAILORx Risk Categorization by Çağlar Ünal, Tolga Özmen, Çetin Ordu, Cihan Uras, Halil Kara, Erhan Gökmen, Mustafa Özdoğan, Orhan Demircan, Kezban Nur Pilancı, Tomris Duymaz, Vahit Özmen

Subjects: Get full text

Association between pathological characteristics and recurrence score by OncotypeDX in resected T1-3 and N0-1 breast cancer: a real-life experience of a North Hungarian regional ce... by Dániel Deme, Bálint Ferenc Tamaskovics, Bálint Ferenc Tamaskovics, Bálint Ferenc Tamaskovics, Nizar Jammoul, Sándor Kovács, Emmanuel Oladunjoye Kayode, James W. Grice, András Telekes

Subjects: Get full text

MCM-2 Levels as a Potential Biomarker for Predicting High-Risk Breast Cancer Patients According to TAILORx Classification by Ünal Ç, Özmen T, İlgün AS, Ordu Ç, Özkurt E, Ak N, Alço G, Erdoğan İyigün Z, Kurt S, Duymaz T, Öztürk MA, Elbüken Çelebi F, Yararbaş K, Soybir G, Aktepe F, Özmen V

Subjects: Get full text